Canakinumab Injection

( DrugBank: Canakinumab / KEGG DRUG: Canakinumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	12

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 10 of 12 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05080218 (ClinicalTrials.gov)	November 15, 2021	6/10/2021	COVID-19 VaccinE Response in Rheumatology Patients	The SARS-CoV-2 Vaccine Response and Safety in Rheumatology Patients and the Influence of Temporary I ...	Rheumatoid Arthritis;Psoriatic Arthritis;Spondylarthritis	Drug: Upadacitinib;Drug: Abatacept;Drug: Secukinumab;Drug: Tofacitinib;Drug: TNF Inhibitor;Drug: Can ...	Jeffrey Curtis	University of Alabama at Birmingham;University of Nebraska;University of Pennsylvania;AbbVie;Bristol ...	Recruiting	18 Years	85 Years	All	1000	Phase 4	United States
2	EUCTR2008-005320-81-ES (EUCTR)	18/02/2009	20/01/2009	Segundo estudio de extensión abierto de 2 años de duración para evaluar la seguridad tolerabilidad y ...	Segundo estudio de extensión abierto de 2 años de duración para evaluar la seguridad tolerabilidad y ...	Artritis Reumatoide MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid art ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Farmacéutica S.A.	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 2	Belgium;Spain;Austria;Germany
3	EUCTR2008-005320-81-BE (EUCTR)	16/02/2009	20/02/2009	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Pharma Services AG	Novartis Pharma Belgium	Not Recruiting			Female: yes Male: yes			Spain;Belgium;Austria;Germany
4	EUCTR2008-005320-81-DE (EUCTR)	06/02/2009	17/11/2008	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	213		Germany;Spain;Austria
5	EUCTR2008-005320-81-AT (EUCTR)	21/10/2008	22/09/2008	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	A 2-year open-label second extension study to evaluate the safety, tolerability and efficacy of cana ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: ACZ885 Product Code: ACZ885 INN or Proposed INN: Canakinumab Other descriptive name: Reco ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	200		Germany;Spain;Austria
6	EUCTR2007-001665-15-IT (EUCTR)	10/12/2007	05/10/2007	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	A 54-week, phase II, multi-center, open-label extension study to evaluate the efficacy, safety and t ...	rheumatoid arthritis MedDRA version: 6.1;Level: PT;Classification code 10039073	Product Name: Canakinumab Product Code: ACZ885	NOVARTIS FARMA	NULL	Not Recruiting			Female: yes Male: yes	179	Phase 2	Germany;Netherlands;Spain;Italy
7	EUCTR2007-000491-16-AT (EUCTR)	06/12/2007	05/04/2007	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885 (an ...	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885 (an ...	Rheumatoid Arthritis MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab(proposed) Other descriptive name: ACZ885 Drug Su ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	260		Germany;Spain;Austria
8	EUCTR2006-004666-14-DE (EUCTR)	17/07/2007	02/04/2007	An exploratory, open label pharmacokinetic – pharmacodynamic study to compare subcutaneous versus in ...	An exploratory, open label pharmacokinetic – pharmacodynamic study to compare subcutaneous versus in ...	Rheumatoid Arthritis MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab(proposed) Other descriptive name: ACZ885 Drug Su ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	32		Germany
9	EUCTR2007-000491-16-BE (EUCTR)	22/06/2007	04/05/2007	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885 (an ...	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885 (an ...	Rheumatoid Arthritis MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab(proposed) Other descriptive name: ACZ885 Drug Su ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes			Spain;Belgium;Austria;Germany
10	EUCTR2007-000491-16-DE (EUCTR)	08/06/2007	22/03/2007	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885 (an ...	A 76-week open-label extension study to evaluate the efficacy, safety and tolerability of ACZ885 (an ...	Rheumatoid Arthritis MedDRA version: 8.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: ACZ885 INN or Proposed INN: Canakinumab (proposed)	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	200		Germany;Spain;Austria

First Previous1 2Next Last